May 2007

InVentiv Health Acquires Addison Whitney

Thursday, May 31, 2007

CenterWatch has been watching for years the goings on at Somerset, N.J.-based inVentiv Health. The billion-dollar company is on another buying spree and we’ve been interested in what it continues to do in the contract research space. In March 2006, inVentiv bought Synergos, a clinical services provider with expertise in clinical trial management services, including project management and monitoring as well as investigator and patient recruitment. Synergos, which was purchased for $5.75 million in cash and stock plus earn-outs, operates under inVentiv’s clinical division.

[Read More]

Cost of Compliance Rising for AHCs

Thursday, May 31, 2007

The Association of Academic Health Centers (AAHC), a non-profit organization supports the nation’s academic health centers, has released a paper reporting that its members are allocating higher amounts of funds towards increasingly burdensome clinical trial compliance requirements. The AAHC placed investing in compliance as its top priority and called the requirements essential for ensuring safe and effective trials. However, the AAHC stated the cost of compliance is a national issue facing the entire academic health center (AHC) enterprise. The report said that for a one-year period, some AHCs reported compliance costs increased as much as 70%. The paper is called Investing in Clinical Trial Compliance.

[Read More]

Recent Industry Personnel News

Tuesday, May 29, 2007

  • MDS Pharma Services, a contract research organization (CRO) based in King of Prussia, Pa. has named James Pusey as the company’s vice president and general manager of its global clinical development business. The group manages MDS’ late stage trials. Prior to MDS, Pusey was chief executive officer at the biotech company OrthoLogic. He also served as executive vice president for neurology at Serono and a vice president of marketing at AstraZeneca’s CNS, Pain and Infection group.

[Read More]

Quintiles Cuts Ribbon On New Research Facility

Friday, May 25, 2007

North Carolina-based CRO Quintiles has opened a new four-story, 236,000-square-foot clinical research facility in Overland Park, Kan. The facility will replace the company’s Clinical Development Services and Clinical Pharmacology units located in Kansas City, Mo., as well a an early phase unit in Lenexa, Kan. The new phase I facility will be three times the space, consisting of 150 beds and room for up to 200 more staff. Quintiles already employs about 750 employees in the Kansas City area.

[Read More]

John Cline Resigns from etrials

Monday, May 21, 2007

Morrisville, N.C.-based eClinical company etrials reported that John Cline, founder and long time chief executive officer of the company, has resigned his post effective immediately in order to pursue other “entrepreneurial endeavors.” He will, however, remain a member of the board of directors.

[Read More]

Senate Okays PDUFA

Friday, May 11, 2007

In a 93-to-1 vote, the U.S. Senate has approved a bill re-authorizing the U.S. Food and Drug Administration (FDA) to collect fees from drug companies to review investigational new drugs. The bill would also require that all phase II and later stage trials for both drugs and devices be listed on the government’s web site, www.clinicaltrials.gov.

[Read More]